Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-030076

President and CEO acquired 11,753 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Chang David D President and CEO 2019-05-13 Other acquisition +11,753 1,125,344 I
Loading xslF345X03/doc4.xml…